Answers are grounded in this paper and cite their sources.
This study examined the feasibility, acceptability, and preliminary effectiveness of CBT-AN-20, a novel 20-session outpatient treatment for anorexia nervosa. A longitudinal case-series study (preregistration: https://doi.org/10.17605/OSF.IO/S2WNY) conducted in adult outpatient eating disorder services assessed CBT-AN-20's feasibility (eligible patients recruited who started treatment, retention, attendance), acceptability (suitability/confidence), and effectiveness (recovery rates, reliable change, outcome measures). Completer analyses indicated high feasibility (recruitment: 84.72%) and moderate-to-high acceptability (retention: 57.38%; session attendance: 84%). Both completer and Intention to Treat (ITT) analyses showed similar improvements in weight, eating pathology, anxiety and depression, all with large effect sizes. Pre-post treatment recovery rates for weight (64.29%) were broadly comparable to CBT-E studies, whereas rates for eating pathology (56.52%) were lower. There was reliable change for eating pathology (70.83%), anxiety (69.23%), and depression (56%). However, the attrition rate means that completer analyses were likely to be over-optimistic about recovery rates (relative to ITT analyses). Future developments should focus on enhancing retention for such patients. Results suggest that CBT-AN-20 may be a viable alternative treatment to CBT-E for some adult outpatients with anorexia nervosa. A fully powered study is needed to validate CBT-AN-20's effectiveness and to explore when change occurs, for whom, and its predictors.
No takes yet. Share an insight, caveat, or question.
Duggan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: